These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 4723308)
21. Polyamide thin-layer chromatographic separation of DOPA metabolites and related compounds. Harrison SD; Chiu P; Maickel RP J Chromatogr; 1973 Oct; 85(1):151-3. PubMed ID: 4754395 [No Abstract] [Full Text] [Related]
22. 3-O-methyldopa, a new precursor of dopamine. Bartholini G; Kuruma I; Pletscher A Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759 [No Abstract] [Full Text] [Related]
23. Comparison of the metabolism of nitrobenzene by hepatic microsomes and cecal microflora from Fischer-344 rats in vitro and the relative importance of each in vivo. Levin AA; Dent JG Drug Metab Dispos; 1982; 10(5):450-4. PubMed ID: 6128191 [No Abstract] [Full Text] [Related]
24. The metabolism of L-3-O-methyldopa, a precursor of dopa in man. Kuruma I; Bartholini G; Tissot R; Pletscher A Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811 [No Abstract] [Full Text] [Related]
25. [Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine]. Valori C; Brunori CA; Renzini V; Porcellati C Ann Ist Super Sanita; 1971; 7(2):414-21. PubMed ID: 5155304 [No Abstract] [Full Text] [Related]
26. Influence of the intestinal microflora on the elimination of warfarin in the rat. Remmel RP; Pohl LR; Elmer GW Drug Metab Dispos; 1981; 9(5):410-4. PubMed ID: 6117438 [TBL] [Abstract][Full Text] [Related]
27. 3,4,5-trimethoxycinnamic acid and related compounds. I. Metabolism by the rat intestinal microflora. Meyer T; Scheline RR Xenobiotica; 1972 Jul; 2(4):383-90. PubMed ID: 4638263 [No Abstract] [Full Text] [Related]
28. Development of a screening test for L-dopa and its metabolites in urine. Routh JI; Bannow RE Clin Chem; 1971 Sep; 17(9):872-4. PubMed ID: 5571486 [No Abstract] [Full Text] [Related]
29. L-dopa, dopamine, and hypomania. Murphy DL; Goodwin FK; Brodie HK; Bunney WE Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751 [No Abstract] [Full Text] [Related]
30. Some molecular parameters influencing rate of reduction of azo compounds by intestinal microflora. Walker R; Ryan AJ Xenobiotica; 1971; 1(4):483-6. PubMed ID: 5006111 [No Abstract] [Full Text] [Related]
31. The origin of urinary tyramine. Formation in tissue and by intestinal microorganisms. Asatoor AM Clin Chim Acta; 1968 Oct; 22(2):223-9. PubMed ID: 5687089 [No Abstract] [Full Text] [Related]
32. A comparison of two media for culturing the anaerobic cecal microflora of mice. Koopman JP; Kennis HM; Lankhorst A; Welling GW; Hectors MP; Nagengast FM; van Druten JA Z Versuchstierkd; 1987; 29(3-4):165-70. PubMed ID: 3617969 [No Abstract] [Full Text] [Related]
33. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain. Wurtman RJ Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596 [No Abstract] [Full Text] [Related]
34. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines]. Uono M; Tanabe H; Yano Y; Nakao K No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082 [No Abstract] [Full Text] [Related]
35. The rate of metabolism of dopamine, dihydroxyphenylacetic acid and methoxytyramine in rabbit brain in vitro. Rutledge CO; Jonason J Eur J Pharmacol; 1968 Oct; 4(3):264-9. PubMed ID: 5723421 [No Abstract] [Full Text] [Related]
36. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease. Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950 [No Abstract] [Full Text] [Related]
37. Metabolism of tyramine-1-14C by the rat. Tacker M; McIsaac WM; Creaven PJ Biochem Pharmacol; 1970 Oct; 19(10):2763-73. PubMed ID: 5478585 [No Abstract] [Full Text] [Related]
38. beta-Aspartylglycine during antibiotic induced dysbacteriosis of intestinal microflora in the rat. Chakhava OV; Ruban SZ; Shustrova NM Prog Clin Biol Res; 1985; 181():159-61. PubMed ID: 4022972 [No Abstract] [Full Text] [Related]
39. The use of a rat-derived microflora for providing colonization resistance in SPF rats. Heidt PJ; Koopman JP; Kennis HM; van den Logt JT; Hectors MP; Nagengast FM; Timmermans CP; de Groot CW Lab Anim; 1990 Oct; 24(4):375-9. PubMed ID: 2148606 [TBL] [Abstract][Full Text] [Related]
40. Metabolism of 3,4-dihydroxyphenylalanine (L-dopa) in human subjects. Goodall M; Alton H Biochem Pharmacol; 1972 Sep; 21(17):2401-8. PubMed ID: 4647074 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]